Partner
In the News
K&S Secures Key Court Victory in Pharmaceutical Pricing Litigation
July 1, 2026
| Law360
Paul Alessio Mezzina
Partner
Nikki Reeves
Partner
Nicholas Andrew Mecsas-Faxon (Nick)
Associate
Cliff Stricklin
Partner
K&S obtains a favorable ruling on behalf of Amgen in a dispute with the state of Colorado over its price cap for the arthritis drug Enbrel.
Third-party coverage:
Amgen Wins Order Blocking Colorado's Enbrel Price Cap (Law360)
Explore King & Spalding
Capabilities
Appellate, Constitutional & Administrative Law
Capabilities
Life Sciences & Healthcare